Home › Companies › PERSPECTIVE THERAPEUTICS INC. › 2024-2025

PERSPECTIVE THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and PERSPECTIVE THERAPEUTICS INC.’s Form 8-K, filed 2025-05-28 (Item 5.07 on EDGAR). Page generated 04 October 2026.

8Reported items
113Asset managers
932Fund votes
2025-05-28Meeting date

Proxy season: 2024-2025 2025-2026

Explore PERSPECTIVE THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by PERSPECTIVE THERAPEUTICS INC.

These tallies are PERSPECTIVE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-28 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PERSPECTIVE THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-05-28
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Lori A. Woods	48,265,909	--	--	4,302,126	8,282,256	Majority: yes
Elect Director: Heidi Henson	41,847,883	--	--	10,720,152	8,282,256	Majority: yes
Elect Director: Frank Morich, M.D., Ph.D.	35,430,823	--	--	17,137,212	8,282,256	Majority: yes
Elect Director: Johan (Thijs) Spoor	51,907,815	--	--	660,220	8,282,256	Majority: yes
Elect Director: Robert Froman Williamson, III	41,915,458	--	--	10,652,577	8,282,256	Majority: yes
Proposal 2: The Auditor Ratification Proposal	59,126,140	1,584,010	140,141	--	--	Majority: yes
Proposal 3: Say on Pay Proposal	38,730,185	13,686,122	151,728	--	8,282,256	Majority: yes

Source: PERSPECTIVE THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-05-28 — read the filing on EDGAR.

How asset managers voted at the PERSPECTIVE THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 113 asset managers that disclosed a PERSPECTIVE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PERSPECTIVE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

SECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

49.2% fund support · no official result

FOR 49.2%AGAINST 50.8%

The 110 asset managers below cast 49.2% of the shares they voted on this item FOR (20,934,855 for, 21,573,834 against).

FOR: 20,934,855 (49.2%)AGAINST: 21,573,834 (50.8%)

Largest asset managers voting on “TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPAN” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	0	18,861,871	Against
Vanguard	2,978,391	920	For
DEERFIELD MANAGEMENT COMPANY, L.P.	2,795,213	0	For
BlackRock	2,684,605	999	For
Avidity Partners Management LP	2,197,270	0	For
Affinity Asset Advisors, LLC	1,909,211	0	For
Octagon Capital Advisors LP	1,744,829	0	For
GEODE CAPITAL MANAGEMENT, LLC	0	1,193,927	Against
Nuveen	1,085,842	0	For
TIAA	1,077,235	0	For
Hills Bank & Trust Co	1,023,628	0	For
Charles Schwab	868,170	0	For
State Street	546,362	2,678	For
Velan Capital Investment Management LP	500,000	0	For
Rock Springs Capital Management LP	0	444,383	Against
Northern Trust	281,526	24	For
Citadel	269,236	0	For
MELLON INVESTMENTS Corp	0	206,840	Against
PORTLAND INVESTMENT COUNSEL INC.	190,000	0	For
Federated Hermes	136,322	0	For
HighVista Strategies LLC	131,179	0	For
Equitable	83,399	41,839	For
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0	125,000	Against
BRIDGEWAY FUNDS INC	0	125,000	Against
MARSHALL WACE, LLP	111,730	0	For

Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.

2. To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Frank Morich, M.D., Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

67% Majority: yes · of votes cast

FOR 67%WITHHELD 33%

FOR: 35,430,823WITHHELD: 17,137,212

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Frank Morich, M.D., Ph.D.”): 35,430,823 for, 17,137,212 withheld, per its Form 8-K filed 2025-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 74,228,334 outstanding shares: 47.7% for, 23% withheld (71% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (4,866,303 for, 0 against).

FOR 31%ABSTAIN 69%

FOR: 4,866,303 (31.1%)ABSTAIN: 10,759,822 (68.9%)

Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Fidelity	1,055,472	8,098,869	Abstain
Vanguard	2,954,376	0	For
BlackRock	0	1,295,470	Abstain
TIAA	0	1,077,235	Abstain
Charles Schwab	434,085	0	For
Equitable	41,839	83,399	Abstain
BRIDGEWAY FUNDS INC	125,000	0	For
Federated Hermes	68,161	0	For
QUANTITATIVE MASTER SERIES LLC	0	66,489	Abstain
Lincoln Financial	37,400	0	For
Global X	0	32,349	Abstain
Northern Trust	0	29,607	Abstain
Goldman Sachs	27,034	0	For
AIG/SunAmerica	26,483	0	For
ETFis Series Trust I	26,440	0	For
Pacific Life	0	20,167	Abstain
John Hancock	20,077	0	For
Nationwide	0	13,974	Abstain
Bridge Builder Trust	0	13,761	Abstain
ProShares	12,693	0	For
Voya	0	10,504	Abstain
DWS	8,205	0	For
SEI	0	7,700	Abstain
Columbia Threadneedle	5,735	0	For
Calvert	0	5,476	Abstain

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

3. To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Heidi Henson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD 20%

FOR: 41,847,883WITHHELD: 10,720,152

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Heidi Henson”): 41,847,883 for, 10,720,152 withheld, per its Form 8-K filed 2025-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 74,228,334 outstanding shares: 56% for, 14% withheld (71% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (7,472,349 for, 0 against).

FOR 47.8%ABSTAIN 52.2%

FOR: 7,472,349 (47.8%)ABSTAIN: 8,153,776 (52.2%)

Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Fidelity	1,055,472	8,098,869	Abstain
Vanguard	2,954,376	0	For
BlackRock	1,295,470	0	For
TIAA	1,077,235	0	For
Charles Schwab	434,085	0	For
Equitable	83,399	41,839	For
BRIDGEWAY FUNDS INC	125,000	0	For
Federated Hermes	68,161	0	For
QUANTITATIVE MASTER SERIES LLC	66,489	0	For
Lincoln Financial	37,400	0	For
Global X	32,349	0	For
Northern Trust	29,607	0	For
Goldman Sachs	27,034	0	For
AIG/SunAmerica	26,483	0	For
ETFis Series Trust I	26,440	0	For
Pacific Life	20,167	0	For
John Hancock	20,077	0	For
Nationwide	6,590	7,384	Abstain
Bridge Builder Trust	13,761	0	For
ProShares	12,693	0	For
Voya	10,504	0	For
DWS	8,205	0	For
SEI	7,700	0	For
Columbia Threadneedle	5,735	0	For
Calvert	0	5,476	Abstain

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

4. To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Johan (Thijs) Spoor

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 51,907,815WITHHELD: 660,220

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Johan (Thijs) Spoor”): 51,907,815 for, 660,220 withheld, per its Form 8-K filed 2025-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 74,228,334 outstanding shares: 70% for, 0.9% withheld (71% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (15,626,125 for, 0 against).

FOR 100%

FOR: 15,626,125 (100.0%)

Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Fidelity	9,154,341	For
Vanguard	2,954,376	For
BlackRock	1,295,470	For
TIAA	1,077,235	For
Charles Schwab	434,085	For
Equitable	125,238	For
BRIDGEWAY FUNDS INC	125,000	For
Federated Hermes	68,161	For
QUANTITATIVE MASTER SERIES LLC	66,489	For
Lincoln Financial	37,400	For
Global X	32,349	For
Northern Trust	29,607	For
Goldman Sachs	27,034	For
AIG/SunAmerica	26,483	For
ETFis Series Trust I	26,440	For
Pacific Life	20,167	For
John Hancock	20,077	For
Nationwide	13,974	For
Bridge Builder Trust	13,761	For
ProShares	12,693	For
Voya	10,504	For
DWS	8,205	For
SEI	7,700	For
Columbia Threadneedle	5,735	For
Calvert	5,476	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

5. To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Lori A. Woods

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 48,265,909WITHHELD: 4,302,126

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Lori A. Woods”): 48,265,909 for, 4,302,126 withheld, per its Form 8-K filed 2025-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 74,228,334 outstanding shares: 65% for, 6% withheld (71% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (15,059,862 for, 0 against).

FOR 96%

FOR: 15,059,862 (96.4%)ABSTAIN: 566,263 (3.6%)

Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Fidelity	9,154,341	0	For
Vanguard	2,954,376	0	For
BlackRock	1,295,470	0	For
TIAA	1,077,235	0	For
Charles Schwab	0	434,085	Abstain
Equitable	125,238	0	For
BRIDGEWAY FUNDS INC	125,000	0	For
Federated Hermes	0	68,161	Abstain
QUANTITATIVE MASTER SERIES LLC	66,489	0	For
Lincoln Financial	37,400	0	For
Global X	0	32,349	Abstain
Northern Trust	29,607	0	For
Goldman Sachs	27,034	0	For
AIG/SunAmerica	26,483	0	For
ETFis Series Trust I	26,440	0	For
Pacific Life	20,167	0	For
John Hancock	20,077	0	For
Nationwide	6,590	7,384	Abstain
Bridge Builder Trust	13,761	0	For
ProShares	12,693	0	For
Voya	0	10,504	Abstain
DWS	8,205	0	For
SEI	0	7,700	Abstain
Columbia Threadneedle	5,735	0	For
Calvert	0	5,476	Abstain

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

6. To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Robert Froman Williamson, III

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD 20%

FOR: 41,915,458WITHHELD: 10,652,577

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert Froman Williamson, III”): 41,915,458 for, 10,652,577 withheld, per its Form 8-K filed 2025-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 74,228,334 outstanding shares: 56% for, 14% withheld (71% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (7,514,188 for, 0 against).

FOR 48.1%ABSTAIN 51.9%

FOR: 7,514,188 (48.1%)ABSTAIN: 8,111,937 (51.9%)

Largest asset managers voting on “To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office u” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Fidelity	1,055,472	8,098,869	Abstain
Vanguard	2,954,376	0	For
BlackRock	1,295,470	0	For
TIAA	1,077,235	0	For
Charles Schwab	434,085	0	For
Equitable	125,238	0	For
BRIDGEWAY FUNDS INC	125,000	0	For
Federated Hermes	68,161	0	For
QUANTITATIVE MASTER SERIES LLC	66,489	0	For
Lincoln Financial	37,400	0	For
Global X	32,349	0	For
Northern Trust	29,607	0	For
Goldman Sachs	27,034	0	For
AIG/SunAmerica	26,483	0	For
ETFis Series Trust I	26,440	0	For
Pacific Life	20,167	0	For
John Hancock	20,077	0	For
Nationwide	6,590	7,384	Abstain
Bridge Builder Trust	13,761	0	For
ProShares	12,693	0	For
Voya	10,504	0	For
DWS	8,205	0	For
SEI	7,700	0	For
Columbia Threadneedle	5,735	0	For
Calvert	0	5,476	Abstain

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

7. To consider and vote on a proposal to ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 59,126,140AGAINST: 1,584,010

PERSPECTIVE THERAPEUTICS INC.’s own tally for this item (“Proposal 2: The Auditor Ratification Proposal”): 59,126,140 for, 1,584,010 against, per its Form 8-K filed 2025-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 74,228,334 outstanding shares: 80% for, 2% against (82% of the company cast a for/against vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (15,626,125 for, 0 against).

FOR 100%

FOR: 15,626,125 (100.0%)

Largest asset managers voting on “To consider and vote on a proposal to ratify the appointment of WithumSmith+Brown, PC as the independent regis” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Fidelity	9,154,341	For
Vanguard	2,954,376	For
BlackRock	1,295,470	For
TIAA	1,077,235	For
Charles Schwab	434,085	For
Equitable	125,238	For
BRIDGEWAY FUNDS INC	125,000	For
Federated Hermes	68,161	For
QUANTITATIVE MASTER SERIES LLC	66,489	For
Lincoln Financial	37,400	For
Global X	32,349	For
Northern Trust	29,607	For
Goldman Sachs	27,034	For
AIG/SunAmerica	26,483	For
ETFis Series Trust I	26,440	For
Pacific Life	20,167	For
John Hancock	20,077	For
Nationwide	13,974	For
Bridge Builder Trust	13,761	For
ProShares	12,693	For
Voya	10,504	For
DWS	8,205	For
SEI	7,700	For
Columbia Threadneedle	5,735	For
Calvert	5,476	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

8. Advisory Vote to Ratify Named Executive Officers' Compensation

COMPENSATION

99.2% fund support · no official result

FOR 99.2%

The 2 asset managers below cast 99.2% of the shares they voted on this item FOR (25,564 for, 200 against).

FOR: 25,564 (99.2%)AGAINST: 200 (0.8%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at PERSPECTIVE THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
JPMorgan	25,564	0	0	0	For
TD Waterhouse Canada Inc.	0	200	0	0	Against

Largest PERSPECTIVE THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of PERSPECTIVE THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 74,228,334 shares outstanding at the time of that meeting.

Top PERSPECTIVE THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	25.41%
2	Vanguard	4.01%
3	DEERFIELD MANAGEMENT COMPANY, L.P.	3.77%
4	BlackRock	3.62%
5	Avidity Partners Management LP	2.96%
6	Affinity Asset Advisors, LLC	2.57%
7	Octagon Capital Advisors LP	2.35%
8	GEODE CAPITAL MANAGEMENT, LLC	1.61%
9	Nuveen	1.46%
10	TIAA	1.45%

Reported PERSPECTIVE THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

PERSPECTIVE THERAPEUTICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Lantheus Alpha Therapy, LLC	15.73%	DEF14A
FMR (Fidelity)	13.54%	13F
FMR LLC	12.79%	DEF14A
Chen Yu	10.66%	13G
Qatar Investment Authority	9.53%	13G
Avidity Partners Management LP	8.15%	13G
Millennium Management LLC	6.59%	13G
BlackRock	5.35%	13F
Vanguard Group	4.13%	13F
Morgan Stanley	2.10%	13F

Percentages above are of 74,228,334 shares outstanding, as reported by PERSPECTIVE THERAPEUTICS INC. on its Form 10-Q dated 2025-05-07 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PERSPECTIVE THERAPEUTICS INC.’s 10-Q dated 2025-05-07. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At PERSPECTIVE THERAPEUTICS INC.'s shareholder meeting held 2025-05-28, in the 2024-2025 proxy season, 113 asset managers reported how they voted in their SEC Form N-PX filings, covering 932 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. PERSPECTIVE THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE… — the reporting funds cast 49.2% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

PERSPECTIVE THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.